<?xml version="1.0" encoding="UTF-8"?>
<ref id="B71-nutrients-11-00068" class="ref">
 <label class="label">71.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Zhou</surname>
    <given-names class="given-names">X.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Zhang</surname>
    <given-names class="given-names">X.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ye</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Zhang</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wang</surname>
    <given-names class="given-names">H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ma</surname>
    <given-names class="given-names">Z.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wu</surname>
    <given-names class="given-names">B.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Nanostructured lipid carriers used for oral delivery of oridonin: An effect of ligand modification on absorption</article-title>
  <source class="source">Int. J. Pharm.</source>
  <year class="year">2015</year>
  <volume class="volume">479</volume>
  <fpage class="fpage">391</fpage>
  <lpage class="lpage">398</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.ijpharm.2014.12.068</pub-id>
  <?supplied-pmid 25556104?>
  <pub-id pub-id-type="pmid" class="pub-id">25556104</pub-id>
 </element-citation>
</ref>
